Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Intervention to help women with trauma-related conditions use HIV prevention medication

Official title: Development and Pilot Testing of a Mental Health Clinic-Based PrEP Uptake and Adherence Intervention for Women in Treatment for Trauma-Related Conditions

Run by The University of Texas Health Science Center, Houston · NCT06558825 · Data updated 2026-11-12

This study is testing a new program to help women dealing with trauma feel more comfortable using HIV prevention medication called PrEP while they receive mental health treatment.

More Substance Use trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment60 (estimated)
SponsorThe University of Texas Health Science Center, Houston
Academic / other
Locations1 site (Houston, Texas)
StatusRecruiting
StartedOctober 1, 2024
Main results expectedMarch 31, 2025
Study endsJune 30, 2025
Registry record updatedDecember 30, 2024
Trial IDNCT06558825 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are cisgender women currently receiving mental health treatment, have a history of trauma, and are at risk for HIV.

Probably not a fit

Patients who are HIV positive or currently participating in another HIV prevention program may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates an integrated bio-behavioral intervention designed to enhance the uptake and adherence of Pre-Exposure Prophylaxis (PrEP) among cisgender women undergoing treatment for trauma-related mental health conditions. The intervention is implemented within a mental health treatment setting and focuses on providing knowledge, behavioral skills, and motivation to engage with PrEP care. The study aims to assess the feasibility, acceptability, and preliminary efficacy of this intervention compared to standard treatment, with the hypothesis that it will lead to higher PrEP uptake and adherence rates.

Why it matters

Potential benefit: If successful, this intervention could significantly improve HIV prevention among women with trauma-related conditions.

How similar studies have gone: Other studies have shown promise in using integrated interventions for HIV prevention, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Currently undergoing mental health treatment;
* Have a history of trauma;
* HIV negative;
* Sexually active with an opposite sex partner within the past 6 months;
* Not using PrEP for HIV prevention at the time of screening;
* Eligible for PrEP based on having at least one Centers for Disease Control and Prevention (CDC)-defined criteria for PrEP;
* Fluent in English;
* Own or have regular access to a smart phone.

Exclusion Criteria:

* HIV positive;
* Concurrently participating in another HIV prevention program;
* Have severe cognitive impairment that would interfere with their ability to consent, understand study procedures and/or effectively participate in therapy;
* Have psychological distress that would prohibit them from participating in the study;
* Be unable or unwilling to meet study requirements.

Where it's running

  • Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston
    Houston, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.